CD4 and Kaposi's sarcoma: Paradoxically, the administration of super physiological doses of Type-I IFN have been shown to have both anti-tumor effects in the treatment of Kaposi sarcoma and anti-viral effects leading to reduction in HIV-RNA levels in patients with high CD4 T cell counts [49], [50].